Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
SThree: Result of Annual General Meeting
SThree: Result of Annual General Meeting
SThree: Result of Annual General Meeting
Turkiye Garanti Bankasi A.S.: Coupon payment of  Covered Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon payment of Covered Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon payment of Covered Bonds to Qualified Investors
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming  Investor Conferences
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming Investor Conferences
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming Investor Conferences
DGAP-News: Photon Energy Group Announces 2022 Financial Guidance
DGAP-News: Photon Energy Group Announces 2022 Financial Guidance
DGAP-News: Photon Energy Group Announces 2022 Financial Guidance
Achiko AG: Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
Achiko AG: Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
Achiko AG: Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
DGAP-News: Plus X Award 2022: Gigaset retail brand of the year again
DGAP-News: Plus X Award 2022: Gigaset retail brand of the year again
DGAP-News: Plus X Award 2022: Gigaset retail brand of the year again
Achiko AG: Achiko secures up to CHF12m equity and debt financing lines with RiverFort  over 3 years
Achiko AG: Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years
Achiko AG: Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years
DGAP-News: Compleo Charging Solutions AG: Framework agreement on wallboxes: Compleo now the hardware partner for ChargeOne
DGAP-News: Compleo Charging Solutions AG: Framework agreement on wallboxes: Compleo now the hardware partner for ChargeOne
DGAP-News: Compleo Charging Solutions AG: Framework agreement on wallboxes: Compleo now the hardware partner for ChargeOne
SWEF: March 2022 NAV
SWEF: March 2022 NAV
SWEF: March 2022 NAV
Genel Energy PLC: Changes to Director's responsibilities
Genel Energy PLC: Changes to Director's responsibilities
Genel Energy PLC: Changes to Director's responsibilities
Multitude SE: Aksels Neilands appointed as Chief Marketing Officer of SweepBank
Multitude SE: Aksels Neilands appointed as Chief Marketing Officer of SweepBank
Multitude SE: Aksels Neilands appointed as Chief Marketing Officer of SweepBank
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Genel Energy PLC: Notice of dividend currency exchange rate
Genel Energy PLC: Notice of dividend currency exchange rate
Genel Energy PLC: Notice of dividend currency exchange rate
DGAP-News: APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy
DGAP-News: APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy
DGAP-News: APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy
DGAP-News: Fandifi Technology takes fan engagement to a new level with Gamification and NFTs
DGAP-News: Fandifi Technology takes fan engagement to a new level with Gamification and NFTs
DGAP-News: Fandifi Technology takes fan engagement to a new level with Gamification and NFTs
Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues
Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues
Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues
Dufry wins new duty-free and duty-paid contract at Sofia International Airport in Bulgaria
Dufry wins new duty-free and duty-paid contract at Sofia International Airport in Bulgaria
Dufry wins new duty-free and duty-paid contract at Sofia International Airport in Bulgaria
Zur Rose Group sees revenue perform as expected in the first  quarter of 2022
Zur Rose Group sees revenue perform as expected in the first quarter of 2022
Zur Rose Group sees revenue perform as expected in the first quarter of 2022
DGAP-Adhoc: 123fahrschule SE publishes preliminary quarterly figures and gives outlook for 2022
DGAP-Adhoc: 123fahrschule SE publishes preliminary quarterly figures and gives outlook for 2022
DGAP-Adhoc: 123fahrschule SE publishes preliminary quarterly figures and gives outlook for 2022
American States Water Company to Report First Quarter 2022 Results: https://mms.businesswire.com/media/20191104005851/en/54588/5/American_States2.logo.jpeg
American States Water Company to Report First Quarter 2022 Results


American States Water Company (NYSE:AWR) announced today that the company intends to release its first quarter ended March 31, 2022 financial results after the market closes on Monday, May 2, 2022

MedinCell provides additional information regarding the new drug application for MDC-IRM: https://mms.businesswire.com/media/20191128005494/en/700687/5/MedinCell-Logo-notagline.jpg
MedinCell provides additional information regarding the new drug application for MDC-IRM


As announced, Teva recently received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) regarding the New Drug Application (NDA) for TV-46000/mdc-IRM.